Triglyceride Lowering Fails to Show CV Benefit in Large Fibrate Trial ...Middle East

In the phase 3 PROMINENT trial, pemafibrate improved multiple lipid fractions in patients with type 2 diabetes, without any impact on cardiovascular events. MDedge News

Hence then, the article about triglyceride lowering fails to show cv benefit in large fibrate trial was published today ( Sunday 06/11/2022 - 12:12 AM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Triglyceride Lowering Fails to Show CV Benefit in Large Fibrate Trial )

Also on site :

• Today’s NYT ‘Strands’ Hints, Spangram and Answers for Saturday, January 17, 2026
• Maison Margiela’s 'Elegant' Duo Perfume Set Makes Fragrance Layering Easy, and It’s Just $30 at Kohl’s 
• Royal Caribbean Extends Pause at Private Caribbean Resort Through 2026—Here’s What Cruisers Are Getting Instead